Search results
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 1 month agoWith its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
Why BioNTech Was a Sickly Stock This Week
Motley Fool· 1 year agoWhat happened BioNTech (NASDAQ: BNTX), a company that rose to great prominence and a high stock price during the coronavirus pandemic, wasn't much of a...
BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoBioNTech SE Sponsored ADR (BNTX) closed at $132.08 in the latest trading session, marking a +1.88%...
All You Need to Know About BioNTech SE Sponsored ADR (BNTX) Rating Upgrade to Buy
Zacks via Yahoo Finance· 1 year agoBioNTech SE Sponsored ADR (BNTX) might move higher on growing optimism about its earnings prospects,...
BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion
Investor's Business Daily· 1 year agoBioNTech said Monday it expects roughly $5.4 billion in sales of its Covid vaccine this year, widely...
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
Motley Fool via Yahoo Finance· 4 months agoMany investors will likely be wearing big smiles as 2023 winds down. The S&P 500 is on track to...
Do Options Traders Know Something About BioNTech (BNTX) Stock We Don't?
Zacks via Yahoo Finance· 2 years agoInvestors in BioNTech SE BNTX need to pay close attention to the stock based on moves in the options...
BioNTech (BNTX) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoOn BioNTech's (BNTX) first-quarter earnings call, investors' focus is expected to be on the sales...
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall...
Motley Fool· 7 months agoBioNTech (NASDAQ: BNTX) has turned in a dismal performance so far this year. The average analysts'...
